USDA Animal and Plant Health Inspection Service (APHIS) announced on January 23, 2025, that it is reinstating its legacy ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

We assign Siegfried a Medium Morningstar Uncertainty Rating. Its business is relatively stable, with high switching costs and good visibility due to long-term customer contracts. However, small ...

Trial decision follows unanticipated events of elevated unconjugated bilirubin levelsCompany advancing multiple next-generation PTH1R agonists ...

CureVac Earns Repeat Recognition by LexisNexis® as One of the World’s Top Innovators CureVac among global top 100 most fast-paced innovators for third consecutive year in acknowledgment of its ...

The top-up is expected to help Singapore compete in areas including AI and quantum computing. Read more at straitstimes.com.

FOSTER CITY, CA, USA I February 18, 2025 I Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions ...

INCHEON, South Korea I 18, 2025 I Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products ...

Of all the risks associated with pharmaceuticals and medical devices, controlling contamination is one of the most important and difficult challenges. Relational risk analysis (ReRA) can help.

JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved… accelant, a leader in sales, marketing, and revenue operations, is thrilled to announc ...